Loading…

The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model

Objective Macrolides have been reported to reduce the exacerbation of severe asthma. The aim of this study was to clarify the effects and mechanisms of EM900, a non-antibiotic macrolide, on allergic airway inflammation. Methods Mice were sensitized and challenged by house dust mite (HDM), then expos...

Full description

Saved in:
Bibliographic Details
Published in:Inflammation research 2020-01, Vol.69 (1), p.139-151
Main Authors: Sadamatsu, Hironori, Takahashi, Koichiro, Tashiro, Hiroki, Kato, Go, Noguchi, Yoshihiko, Kurata, Keigo, Ōmura, Satoshi, Kimura, Shinya, Sunazuka, Toshiaki, Sueoka-Aragane, Naoko
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c523t-52e170eab4d225589cb9cc48ea6a513decc666bb60636210eaad3fd238073aac3
cites cdi_FETCH-LOGICAL-c523t-52e170eab4d225589cb9cc48ea6a513decc666bb60636210eaad3fd238073aac3
container_end_page 151
container_issue 1
container_start_page 139
container_title Inflammation research
container_volume 69
creator Sadamatsu, Hironori
Takahashi, Koichiro
Tashiro, Hiroki
Kato, Go
Noguchi, Yoshihiko
Kurata, Keigo
Ōmura, Satoshi
Kimura, Shinya
Sunazuka, Toshiaki
Sueoka-Aragane, Naoko
description Objective Macrolides have been reported to reduce the exacerbation of severe asthma. The aim of this study was to clarify the effects and mechanisms of EM900, a non-antibiotic macrolide, on allergic airway inflammation. Methods Mice were sensitized and challenged by house dust mite (HDM), then exposed to polyinosinic-polycytidylic acid (poly(I:C)) as a model of asthma complicated with viral infection. Mice were administered with EM900. Airway inflammation was assessed from inflammatory cells in bronchoalveolar lavage fluid (BALF) and cytokines in lung tissues. Lung interstitial macrophages were counted by flow cytometry. Cytokine production, phosphorylation of NF-κB, and p38 in macrophages were examined by ELISA and western blotting. Results Counts of cells in BALF and concentrations of IL-13, IL-5, RANTES, IL-17A, and MIP-2 were significantly decreased by EM900 compared to those without EM900. Percentages of lung interstitial macrophages were significantly decreased with EM900. Concentrations of IL-6, RANTES, and MIP-2 induced by HDM and poly(I:C) were significantly suppressed by EM900 through the suppression of NF-κB and p38 phosphorylation in macrophages. Conclusions HDM and poly(I:C)-induced airway inflammation is attenuated by EM900 with the inhibition of lung interstitial macrophages. Clinical use of EM900 is expected, because EM900 has inhibitory effects against airway inflammation without inducing bacterial drug resistance.
doi_str_mv 10.1007/s00011-019-01302-3
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6942021</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2332279708</sourcerecordid><originalsourceid>FETCH-LOGICAL-c523t-52e170eab4d225589cb9cc48ea6a513decc666bb60636210eaad3fd238073aac3</originalsourceid><addsrcrecordid>eNp9kctu1TAQhiMEoqXwAiyQJTZlERjbubKohA6FVmrFpkjsrIntnLhK7EPsUJ1n4KUZmlIuCxa-zje_PfNn2XMOrzlA_SYCAOc58JaGBJHLB9khLwTkLTRfHtIehMxlI-EgexLjNeGNaMTj7EDyRgCI4jD7fjVY5oPP0SfXuZCcZhPqOYzOWHZ62QIwTMn6BZON7Oz9JUNv2C6M--Pzt5tXufNm0dYwdPMN7pnz_YjThMkFz25cGuhmIOHbc-hX7d2AWxJzniGbwhItzcaOT7NHPY7RPrtbj7LPH06vNmf5xaeP55t3F7kuhUx5KSyvwWJXGCHKsml112pdNBYrLLk0VuuqqrqugkpWghOJRvZGyAZqiajlUXay6u6WbrJGW59mHNVudhPOexXQqb8j3g1qG76pqqXmCk4Cx3cCc_i62JjU5KK244jeUjlKSCGLmhe8JfTlP-h1WGZP5RElhajbGhqixEpRc2KcbX__GQ7qp9dq9VqR1-rWayUp6cWfZdyn_DKXALkCkUJ-a-ffb_9H9gfj47YB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2332279708</pqid></control><display><type>article</type><title>The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model</title><source>Springer Link</source><creator>Sadamatsu, Hironori ; Takahashi, Koichiro ; Tashiro, Hiroki ; Kato, Go ; Noguchi, Yoshihiko ; Kurata, Keigo ; Ōmura, Satoshi ; Kimura, Shinya ; Sunazuka, Toshiaki ; Sueoka-Aragane, Naoko</creator><creatorcontrib>Sadamatsu, Hironori ; Takahashi, Koichiro ; Tashiro, Hiroki ; Kato, Go ; Noguchi, Yoshihiko ; Kurata, Keigo ; Ōmura, Satoshi ; Kimura, Shinya ; Sunazuka, Toshiaki ; Sueoka-Aragane, Naoko</creatorcontrib><description>Objective Macrolides have been reported to reduce the exacerbation of severe asthma. The aim of this study was to clarify the effects and mechanisms of EM900, a non-antibiotic macrolide, on allergic airway inflammation. Methods Mice were sensitized and challenged by house dust mite (HDM), then exposed to polyinosinic-polycytidylic acid (poly(I:C)) as a model of asthma complicated with viral infection. Mice were administered with EM900. Airway inflammation was assessed from inflammatory cells in bronchoalveolar lavage fluid (BALF) and cytokines in lung tissues. Lung interstitial macrophages were counted by flow cytometry. Cytokine production, phosphorylation of NF-κB, and p38 in macrophages were examined by ELISA and western blotting. Results Counts of cells in BALF and concentrations of IL-13, IL-5, RANTES, IL-17A, and MIP-2 were significantly decreased by EM900 compared to those without EM900. Percentages of lung interstitial macrophages were significantly decreased with EM900. Concentrations of IL-6, RANTES, and MIP-2 induced by HDM and poly(I:C) were significantly suppressed by EM900 through the suppression of NF-κB and p38 phosphorylation in macrophages. Conclusions HDM and poly(I:C)-induced airway inflammation is attenuated by EM900 with the inhibition of lung interstitial macrophages. Clinical use of EM900 is expected, because EM900 has inhibitory effects against airway inflammation without inducing bacterial drug resistance.</description><identifier>ISSN: 1023-3830</identifier><identifier>EISSN: 1420-908X</identifier><identifier>DOI: 10.1007/s00011-019-01302-3</identifier><identifier>PMID: 31820024</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Allergology ; Alveoli ; Antibiotics ; Asthma ; Biomedical and Life Sciences ; Biomedicine ; Bronchus ; Cytokines ; Dermatology ; Drug resistance ; Flow cytometry ; House dust ; Immunology ; Inflammation ; Interleukin 13 ; Interleukin 5 ; Interleukin 6 ; Lungs ; Macrophage inflammatory protein ; Macrophages ; Neurology ; NF-κB protein ; Original Research Paper ; Pharmacology/Toxicology ; Phosphorylation ; Polyinosinic:polycytidylic acid ; RANTES ; Respiratory tract ; Respiratory tract diseases ; Rheumatology ; Western blotting</subject><ispartof>Inflammation research, 2020-01, Vol.69 (1), p.139-151</ispartof><rights>The Author(s) 2019</rights><rights>Inflammation Research is a copyright of Springer, (2019). All Rights Reserved. © 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c523t-52e170eab4d225589cb9cc48ea6a513decc666bb60636210eaad3fd238073aac3</citedby><cites>FETCH-LOGICAL-c523t-52e170eab4d225589cb9cc48ea6a513decc666bb60636210eaad3fd238073aac3</cites><orcidid>0000-0003-0461-5072</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31820024$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sadamatsu, Hironori</creatorcontrib><creatorcontrib>Takahashi, Koichiro</creatorcontrib><creatorcontrib>Tashiro, Hiroki</creatorcontrib><creatorcontrib>Kato, Go</creatorcontrib><creatorcontrib>Noguchi, Yoshihiko</creatorcontrib><creatorcontrib>Kurata, Keigo</creatorcontrib><creatorcontrib>Ōmura, Satoshi</creatorcontrib><creatorcontrib>Kimura, Shinya</creatorcontrib><creatorcontrib>Sunazuka, Toshiaki</creatorcontrib><creatorcontrib>Sueoka-Aragane, Naoko</creatorcontrib><title>The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model</title><title>Inflammation research</title><addtitle>Inflamm. Res</addtitle><addtitle>Inflamm Res</addtitle><description>Objective Macrolides have been reported to reduce the exacerbation of severe asthma. The aim of this study was to clarify the effects and mechanisms of EM900, a non-antibiotic macrolide, on allergic airway inflammation. Methods Mice were sensitized and challenged by house dust mite (HDM), then exposed to polyinosinic-polycytidylic acid (poly(I:C)) as a model of asthma complicated with viral infection. Mice were administered with EM900. Airway inflammation was assessed from inflammatory cells in bronchoalveolar lavage fluid (BALF) and cytokines in lung tissues. Lung interstitial macrophages were counted by flow cytometry. Cytokine production, phosphorylation of NF-κB, and p38 in macrophages were examined by ELISA and western blotting. Results Counts of cells in BALF and concentrations of IL-13, IL-5, RANTES, IL-17A, and MIP-2 were significantly decreased by EM900 compared to those without EM900. Percentages of lung interstitial macrophages were significantly decreased with EM900. Concentrations of IL-6, RANTES, and MIP-2 induced by HDM and poly(I:C) were significantly suppressed by EM900 through the suppression of NF-κB and p38 phosphorylation in macrophages. Conclusions HDM and poly(I:C)-induced airway inflammation is attenuated by EM900 with the inhibition of lung interstitial macrophages. Clinical use of EM900 is expected, because EM900 has inhibitory effects against airway inflammation without inducing bacterial drug resistance.</description><subject>Allergology</subject><subject>Alveoli</subject><subject>Antibiotics</subject><subject>Asthma</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Bronchus</subject><subject>Cytokines</subject><subject>Dermatology</subject><subject>Drug resistance</subject><subject>Flow cytometry</subject><subject>House dust</subject><subject>Immunology</subject><subject>Inflammation</subject><subject>Interleukin 13</subject><subject>Interleukin 5</subject><subject>Interleukin 6</subject><subject>Lungs</subject><subject>Macrophage inflammatory protein</subject><subject>Macrophages</subject><subject>Neurology</subject><subject>NF-κB protein</subject><subject>Original Research Paper</subject><subject>Pharmacology/Toxicology</subject><subject>Phosphorylation</subject><subject>Polyinosinic:polycytidylic acid</subject><subject>RANTES</subject><subject>Respiratory tract</subject><subject>Respiratory tract diseases</subject><subject>Rheumatology</subject><subject>Western blotting</subject><issn>1023-3830</issn><issn>1420-908X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kctu1TAQhiMEoqXwAiyQJTZlERjbubKohA6FVmrFpkjsrIntnLhK7EPsUJ1n4KUZmlIuCxa-zje_PfNn2XMOrzlA_SYCAOc58JaGBJHLB9khLwTkLTRfHtIehMxlI-EgexLjNeGNaMTj7EDyRgCI4jD7fjVY5oPP0SfXuZCcZhPqOYzOWHZ62QIwTMn6BZON7Oz9JUNv2C6M--Pzt5tXufNm0dYwdPMN7pnz_YjThMkFz25cGuhmIOHbc-hX7d2AWxJzniGbwhItzcaOT7NHPY7RPrtbj7LPH06vNmf5xaeP55t3F7kuhUx5KSyvwWJXGCHKsml112pdNBYrLLk0VuuqqrqugkpWghOJRvZGyAZqiajlUXay6u6WbrJGW59mHNVudhPOexXQqb8j3g1qG76pqqXmCk4Cx3cCc_i62JjU5KK244jeUjlKSCGLmhe8JfTlP-h1WGZP5RElhajbGhqixEpRc2KcbX__GQ7qp9dq9VqR1-rWayUp6cWfZdyn_DKXALkCkUJ-a-ffb_9H9gfj47YB</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Sadamatsu, Hironori</creator><creator>Takahashi, Koichiro</creator><creator>Tashiro, Hiroki</creator><creator>Kato, Go</creator><creator>Noguchi, Yoshihiko</creator><creator>Kurata, Keigo</creator><creator>Ōmura, Satoshi</creator><creator>Kimura, Shinya</creator><creator>Sunazuka, Toshiaki</creator><creator>Sueoka-Aragane, Naoko</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0461-5072</orcidid></search><sort><creationdate>20200101</creationdate><title>The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model</title><author>Sadamatsu, Hironori ; Takahashi, Koichiro ; Tashiro, Hiroki ; Kato, Go ; Noguchi, Yoshihiko ; Kurata, Keigo ; Ōmura, Satoshi ; Kimura, Shinya ; Sunazuka, Toshiaki ; Sueoka-Aragane, Naoko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c523t-52e170eab4d225589cb9cc48ea6a513decc666bb60636210eaad3fd238073aac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Allergology</topic><topic>Alveoli</topic><topic>Antibiotics</topic><topic>Asthma</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Bronchus</topic><topic>Cytokines</topic><topic>Dermatology</topic><topic>Drug resistance</topic><topic>Flow cytometry</topic><topic>House dust</topic><topic>Immunology</topic><topic>Inflammation</topic><topic>Interleukin 13</topic><topic>Interleukin 5</topic><topic>Interleukin 6</topic><topic>Lungs</topic><topic>Macrophage inflammatory protein</topic><topic>Macrophages</topic><topic>Neurology</topic><topic>NF-κB protein</topic><topic>Original Research Paper</topic><topic>Pharmacology/Toxicology</topic><topic>Phosphorylation</topic><topic>Polyinosinic:polycytidylic acid</topic><topic>RANTES</topic><topic>Respiratory tract</topic><topic>Respiratory tract diseases</topic><topic>Rheumatology</topic><topic>Western blotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sadamatsu, Hironori</creatorcontrib><creatorcontrib>Takahashi, Koichiro</creatorcontrib><creatorcontrib>Tashiro, Hiroki</creatorcontrib><creatorcontrib>Kato, Go</creatorcontrib><creatorcontrib>Noguchi, Yoshihiko</creatorcontrib><creatorcontrib>Kurata, Keigo</creatorcontrib><creatorcontrib>Ōmura, Satoshi</creatorcontrib><creatorcontrib>Kimura, Shinya</creatorcontrib><creatorcontrib>Sunazuka, Toshiaki</creatorcontrib><creatorcontrib>Sueoka-Aragane, Naoko</creatorcontrib><collection>SpringerOpen (Open Access)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Inflammation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sadamatsu, Hironori</au><au>Takahashi, Koichiro</au><au>Tashiro, Hiroki</au><au>Kato, Go</au><au>Noguchi, Yoshihiko</au><au>Kurata, Keigo</au><au>Ōmura, Satoshi</au><au>Kimura, Shinya</au><au>Sunazuka, Toshiaki</au><au>Sueoka-Aragane, Naoko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model</atitle><jtitle>Inflammation research</jtitle><stitle>Inflamm. Res</stitle><addtitle>Inflamm Res</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>69</volume><issue>1</issue><spage>139</spage><epage>151</epage><pages>139-151</pages><issn>1023-3830</issn><eissn>1420-908X</eissn><abstract>Objective Macrolides have been reported to reduce the exacerbation of severe asthma. The aim of this study was to clarify the effects and mechanisms of EM900, a non-antibiotic macrolide, on allergic airway inflammation. Methods Mice were sensitized and challenged by house dust mite (HDM), then exposed to polyinosinic-polycytidylic acid (poly(I:C)) as a model of asthma complicated with viral infection. Mice were administered with EM900. Airway inflammation was assessed from inflammatory cells in bronchoalveolar lavage fluid (BALF) and cytokines in lung tissues. Lung interstitial macrophages were counted by flow cytometry. Cytokine production, phosphorylation of NF-κB, and p38 in macrophages were examined by ELISA and western blotting. Results Counts of cells in BALF and concentrations of IL-13, IL-5, RANTES, IL-17A, and MIP-2 were significantly decreased by EM900 compared to those without EM900. Percentages of lung interstitial macrophages were significantly decreased with EM900. Concentrations of IL-6, RANTES, and MIP-2 induced by HDM and poly(I:C) were significantly suppressed by EM900 through the suppression of NF-κB and p38 phosphorylation in macrophages. Conclusions HDM and poly(I:C)-induced airway inflammation is attenuated by EM900 with the inhibition of lung interstitial macrophages. Clinical use of EM900 is expected, because EM900 has inhibitory effects against airway inflammation without inducing bacterial drug resistance.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>31820024</pmid><doi>10.1007/s00011-019-01302-3</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-0461-5072</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1023-3830
ispartof Inflammation research, 2020-01, Vol.69 (1), p.139-151
issn 1023-3830
1420-908X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6942021
source Springer Link
subjects Allergology
Alveoli
Antibiotics
Asthma
Biomedical and Life Sciences
Biomedicine
Bronchus
Cytokines
Dermatology
Drug resistance
Flow cytometry
House dust
Immunology
Inflammation
Interleukin 13
Interleukin 5
Interleukin 6
Lungs
Macrophage inflammatory protein
Macrophages
Neurology
NF-κB protein
Original Research Paper
Pharmacology/Toxicology
Phosphorylation
Polyinosinic:polycytidylic acid
RANTES
Respiratory tract
Respiratory tract diseases
Rheumatology
Western blotting
title The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A27%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20non-antibiotic%20macrolide%20EM900%20attenuates%20HDM%20and%20poly(I:C)-induced%20airway%20inflammation%20with%20inhibition%20of%20macrophages%20in%20a%20mouse%20model&rft.jtitle=Inflammation%20research&rft.au=Sadamatsu,%20Hironori&rft.date=2020-01-01&rft.volume=69&rft.issue=1&rft.spage=139&rft.epage=151&rft.pages=139-151&rft.issn=1023-3830&rft.eissn=1420-908X&rft_id=info:doi/10.1007/s00011-019-01302-3&rft_dat=%3Cproquest_pubme%3E2332279708%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c523t-52e170eab4d225589cb9cc48ea6a513decc666bb60636210eaad3fd238073aac3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2332279708&rft_id=info:pmid/31820024&rfr_iscdi=true